Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of Δ9-Tetrahydrocannabinolic Acid A

Cannabis and Cannabinoid Research

Volumn 1, Issue 1, 2016, Pages 124-130

  Moreno Sanz, Guillermo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

THC; THC COOH; THCA A

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; PHOSPHOLIPASE C; TETRAHYDROCANNABINOLIC ACID; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; DECARBOXYLATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IC50; IMMUNOMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW;

EID: 85019504422     PISSN: None     EISSN: 23788763     Source Type: Journal    
DOI: 10.1089/can.2016.0008     Document Type: Review

References (49)

1. Yamauchi T, Shoyama Y, Aramaki H, et al. Tetrahydrocannabinolic acid, a genuine substance of tetrahydrocannabinol. Chem Pharm Bull (Tokyo). 1967;15:1075-1076.
2. Sirikantaramas S, Taura F, Tanaka Y, et al. Tetrahydrocannabinolic acid synthase, the enzyme controlling marijuana psychoactivity, is secreted into the storage cavity of the glandular trichomes. Plant Cell Physiol. 2005;46:1578-1582.
3. Morimoto S, Tanaka Y, Sasaki K, et al. Identification and characterization of cannabinoids that induce cell death through mitochondrial permeability transition in Cannabis leaf cells. J Biol Chem. 2007;282:20739-20751.
4. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42:327-360.
5. Jung J, Kempf J, Mahler H, et al. Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LCMS/ MS. J Mass Spectrom. 2007;42:354-360.
6. Moore C, Rana S, Coulter C. Simultaneous identification of 2-carboxytetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;852:459-464.
7. Dussy FE, Hamberg C, Luginbuhl M, et al. Isolation of Delta9-THCA-A from hemp and analytical aspects concerning the determination of Delta9-THC in cannabis products. Forensic Sci Int. 2005;149:3-10.
8. Jung J, Meyer MR, Maurer HH, et al. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques. J Mass Spectrom. 2009;44:1423-1433.
9. Raikos N, Schmid H, Nussbaumer S, et al. Determination of Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis. Forensic Sci Int. 2014;243:130-136.
10. Ruhaak LR, Felth J, Karlsson PC, et al. Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa. Biol Pharm Bull. 2011;34:774-778.
11. Verhoeckx KC, Korthout HA, van Meeteren-Kreikamp AP, et al. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways. Int Immunopharmacol. 2006;6:656-665.
12. Moldzio R, Pacher T, Krewenka C, et al. Effects of cannabinoids Delta(9)-tetrahydrocannabinol, Delta(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures. Phytomedicine. 2012;19:819-824.
13. Ligresti A, Moriello AS, Starowicz K, et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther. 2006;318:1375-1387.
14. De Petrocellis L, Ligresti A, Schiano Moriello A, et al. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. Br J Pharmacol. 2013;168:79-102.
15. Rock EM, Kopstick RL, Limebeer CL, et al. Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. Br J Pharmacol. 2013;170:641-648.
16. Shoyama Y, Tamada T, Kurihara K, et al. Structure and function of 1-tetrahydrocannabinolic acid (THCA) synthase, the enzyme controlling the psychoactivity of Cannabis sativa. J Mol Biol. 2012;423:96-105.
17. Kojoma M, Seki H, Yoshida S, et al. DNA polymorphisms in the tetrahydrocannabinolic acid (THCA) synthase gene in ''drug-type'' and ''fibertype'' Cannabis sativa L. Forensic Sci Int. 2006;159:132-140.
18. Staginnus C, Zorntlein S, de Meijer E. A PCR marker linked to a THCA synthase polymorphism is a reliable tool to discriminate potentially THCrich plants of Cannabis sativa L. J Forensic Sci. 2014;59:919-926.
19. Happyana N, Agnolet S, Muntendam R, et al. Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. Phytochemistry. 2013;87:51-59.
20. Sirikantaramas S, Morimoto S, Shoyama Y, et al. The gene controlling marijuana psychoactivity: molecular cloning and heterologous expression of Delta1-tetrahydrocannabinolic acid synthase from Cannabis sativa L. J Biol Chem. 2004;279:39767-39774.
21. Taura F, Dono E, Sirikantaramas S, et al. Production of Delta(1)-tetrahydrocannabinolic acid by the biosynthetic enzyme secreted from transgenic Pichia pastoris. Biochem Biophys Res Commun. 2007;361:675-680.
22. Lange K, Schmid A, Julsing MK. Delta(9)-Tetrahydrocannabinolic acid synthase production in Pichia pastoris enables chemical synthesis of cannabinoids. J Biotechnol. 2015;211:68-76.
23. Zirpel B, Stehle F, Kayser O. Production of Delta9-tetrahydrocannabinolic acid from cannabigerolic acid by whole cells of Pichia (Komagataella) pastoris expressing Delta9-tetrahydrocannabinolic acid synthase from Cannabis sativa L. Biotechnol Lett. 2015;37:1869-1875.
24. Korte F, Haag M, Claussen U. Tetrahydrocannabinolcarboxylic acid, a component of hashish. Angew Chem Int Ed Engl. 1965;4:872.
25. Mechoulam R, Ben-Zvi Z, Yagnitinsky B, et al. A new tetrahydrocannabinolic acid. Tetrahedron Lett. 1969:2339-2341.
26. De Zeeuw RA, Malingre TM, Merkus FW. 1-tetrahydrocannabinolic acid, an important component in the evaluation of cannabis products. J Pharm Pharmacol. 1972;24:1-6.
27. Agurell S, Nilsson IM, Ohlsson A, et al. On the metabolism of tritiumlabelled 1-tetrahydrocannabinol in the rabbit. Biochem Pharmacol. 1970;19:1333-1339.
28. Wall ME, Perez-Reyes M. The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man. J Clin Pharmacol. 1981;21:178S-189S.
29. Martin BR, Compton DR, Prescott WR, et al. Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction. Drug Alcohol Depend. 1995;37:231-240.
30. Husni AS, McCurdy CR, Radwan MM, et al. Evaluation of phytocannabinoids from high potency using bioassays to determine structure-activity relationships for Cannabinoid Receptor 1 and Cannabinoid Receptor 2. Med Chem Res. 2014;23:4295-4300.
31. Burdick D, DeOrazio R, Guzzo P, et al. Synthesis and structure-activity relationship of substitutions at the C-1 position of Delta9-tetrahydrocannabinol. Bioorg Med Chem Lett. 2010;20:1424-1426.
32. Ahmed SA, Ross SA, Slade D, et al. Cannabinoid ester constituents from high-potency Cannabis sativa. J Nat Prod. 2008;71:536-542.
33. Rosenthaler S, Pohn B, Kolmanz C, et al. Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures. Neurotoxicol Teratol. 2014;46:49-56.
34. Van Sickle MD, Oland LD, Ho W, et al. Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology. 2001;121:767-774.
35. Van Sickle MD, Oland LD, Mackie K, et al. Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am J Physiol Gastrointest Liver Physiol. 2003;285:G566-G576.
36. Darmani NA, Johnson JC. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. Eur J Pharmacol. 2004;488:201-212.
37. Parker LA, Rock EM, Limebeer CL. Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol. 2011;163:1411-1422.
38. Schmeling WT, Hosko MJ. Effect of delta 9-tetrahydrocannabinol on hypothalamic thermosensitive units. Brain Res. 1980;187:431-442.
39. Wu X, French ED. Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment. Neuropharmacology. 2000;39:391-398.
40. Spiro AS, Wong A, Boucher AA, et al. Enhanced brain disposition and effects of Delta9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice. PLoS One. 2012;7:e35937.
41. Agarwal S, Elmquist WF. Insight into the cooperation of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) at the blood-brain barrier: a case study examining sorafenib efflux clearance. Mol Pharm. 2012;9:678-684.
42. Moreno-Sanz G, Duranti A, Melzig L, et al. Synthesis and structure-activity relationship studies of O-Biphenyl-3-yl carbamates as peripherally restricted fatty acid amide hydrolase inhibitors. J Med Chem. 2013;56:5917-5930.
43. Alozie SO, Martin BR, Harris LS, et al. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain. Pharmacol Biochem Behav. 1980;12:217-221.
44. Deiana S, Watanabe A, Yamasaki Y, et al. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarin (CBDV), Delta(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacology (Berl). 2012;219:859-873.
45. De Petrocellis L, Ligresti A, Moriello AS, et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011;163:1479-1494.
46. Qamri Z, Preet A, Nasser MW, et al. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Mol Cancer Ther. 2009;8:3117-3129.
47. Abalsamo L, Spadaro F, Bozzuto G, et al. Inhibition of phosphatidylcholinespecific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells. Breast Cancer Res. 2012;14:R50.
48. Hazekamp A, Bastola K, Rashidi H, et al. Cannabis tea revisited: a systematic evaluation of the cannabinoid composition of cannabis tea. J Ethnopharmacol. 2007;113:85-90.
49. Eichler M, Spinedi L, Unfer-Grauwiler S, et al. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects. Planta Med. 2012;78:686-691.